Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Task-guided accelerated cTBS simultaneously treats depression and social dysfunction in patients with major depressive disorder: a randomized clinical trial
    Published on 2026-02-19
    3 months ago
  • Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine
    Published on 2026-02-18
    3 months ago
  • Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence
    Published on 2026-02-17
    3 months ago
  • Disinhibition of ventral tegmental area during initial punishment learning causes enduring punishment insensitivity
    Published on 2026-02-16
    3 months ago
  • The puzzle of heterogeneity: an introduction to part II
    Published on 2026-02-14
    3 months ago
  • Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway
    Published on 2026-02-12
    4 months ago
  • Mechanistic signatures of comorbid PTSD with cognitive impairment implicate cortisol-induced neural toxicity
    Published on 2026-02-11
    4 months ago
« Previous 1 … 11 12 13 14 15 … 143 Next »
Journal of Psychopharmacology
  • The role of psychopharmacology and cognitive neuroscience in understanding the brain in the treatment of psychiatric disorders and neurological diseases for the benefit of society
    Published on 2025-12-01
    6 months ago
  • “Too small to succeed?” Rethinking efficacy claims in a solriamfetol trial for ME/CFS
    Published on 2025-12-01
    6 months ago
  • A Bayesian network meta-analysis of randomized controlled trials comparing the efficacy and safety of cholinergic modulators in schizophrenia
    Published on 2025-12-01
    6 months ago
  • Psychedelic research – Going global
    Published on 2025-12-01
    6 months ago
  • (-)-OSU6162 reduces freezing elicited by context-conditioned fear in rats
    Published on 2025-11-29
    6 months ago
  • Exploring early add-on celecoxib treatment in OCD: Results from a preliminary randomized, double-blind, placebo-controlled trial
    Published on 2025-11-28
    6 months ago
  • Intracerebroventricular knockdown of NPY1R disrupts NPY1R-GALR2/TrkB heteroreceptor complexes without affecting neuroplasticity or depressive-like behaviour
    Published on 2025-11-27
    6 months ago
« Previous 1 … 11 12 13 14 15 … 146 Next »
European Neuropsychopharmacology
  • Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial
    Published on 2025-12-15
    6 months ago
  • Are cell type-specific methylation profiles the missing link in ADHD epigenetics?
    Published on 2025-12-14
    6 months ago
  • Dynamic functional network connectivity impairment in bipolar disorder and its relationship with global functioning
    Published on 2025-12-13
    6 months ago
  • Different effect of adverse childhood experiences on white matter microstructure in major depression and bipolar disorder: moderating role of genetic liability
    Published on 2025-12-13
    6 months ago
  • Association between tirzepatide use and risk of mortality, hospitalization, and suicidal behavior in patients with schizophrenia spectrum disorders: A one-year retrospective cohort study of 3618 patients
    Published on 2025-12-12
    6 months ago
  • Editorial Board
    Published on 2025-12-11
    6 months ago
  • The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
    Published on 2025-12-03
    6 months ago
« Previous 1 … 11 12 13 14 15 … 166 Next »

   Pharma Pub